NSC 828467
NSC 828467 exhibited significant in vitro anticancer activity, and it is one of the top-five CA IX inhibitors with an IC50 value of 27.2nM.
Product Specifications
UNSPSC
12352005
Target
Carbonic Anhydrase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nsc-828467.html
Solubility
10 mM in DMSO
Smiles
NS(=O)(C1=CC=C(C=C1)NC2=NC(N/N=C/C3=NC=CC=C3)=NC(NC4=CC=CC=C4)=N2)=O
Molecular Formula
C21H19N9O2S
Molecular Weight
461.50
References & Citations
[1]Tawfik HO, et al. Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach. Eur J Med Chem. 2022 Feb 12;232:114190.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY422980 100 µg
C1ORF190 (LURAP1) (NM_001013615) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNCB0674-500 1x 500 µL
Cytokeratin 10 (LH2), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details